B lymphocyte Tolerance in Health and Autoimmunity
B lymphocyte Tolerance in Health and Autoimmunity
批准号:
7215734
负责人:
DAVID NEMAZEE
金额:
$37.55万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-07-01 至 2010-03-31
关键词:
AffectAntibody FormationAntigen-Presenting CellsAntigensAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityB-Cell DevelopmentB-Lymphocyte SubsetsB-LymphocytesBiologicalCell LineageCell Surface ReceptorsCell SurvivalCell physiologyCell surfaceCellsCellular biologyComplement Factor BCytokine ReceptorsDefectDevelopmentDiscriminationDiseaseEnsureFamilyGenerationsGenetic ModelsGoalsGrantHealthImmune ToleranceImmune systemKnock-outLupusLymphoidModelingMusMutationMyelogenousPTPN6 genePathway interactionsPeripheralPhenotypePlayProcessPropertyReceptor SignalingRegulationRoleSignal PathwaySignal TransductionT-Independent AntigensT-LymphocyteTNF geneTestingTimeTissuesToll-Like Receptor 1Toll-like receptorsTumor Necrosis Factor ReceptorWorkcytokinehuman PTPN6 proteinin vivopreventreceptorresearch studyresponse
中文摘要
描述(由申请人提供):这是RO1资助的续期申请,用于研究外周B细胞的耐受性。一些证据,包括之前对这项授权的工作,已经表明外周B细胞耐受发生,通常是通过缺失。这种耐受性是自身免疫性疾病发展的障碍。然而,外周的B细胞也必须能够对外来抗原做出反应。B淋巴细胞受许多信号通路的调节,以确保适当的发育、激活和免疫耐受。在这项建议中,我们集中在三个途径,调节外周免疫系统中B细胞亚群的发展,外周B细胞对组织特异性自身抗原的耐受性,以及T非依赖性抗体反应。影响Toll样受体、细胞表面抑制受体和肿瘤坏死因子家族细胞因子BAFF受体信号通路的突变将被用来探讨它们在B细胞自主生物反应中的作用。第一个目标是评估所有TLR信号缺陷小鼠的B细胞发育、B细胞耐受性和TI-2反应。在目标2中,将评估抑制或消除B细胞中SHP-1对外周B细胞耐受性和TI-2反应的影响。Aim 3的实验验证了TACI缺陷的B细胞由于BAFF信号的失调而具有特定的外周耐受缺陷的预测,并试图确定TACI在TI-2反应中的B细胞自主作用。这些研究的长期目标是了解自我/非自我歧视是如何产生的,自身免疫的发展过程中出了什么问题,并找出了可以通过操纵这些机制来改善或预防疾病的方法。
英文摘要
DESCRIPTION (provided by applicant): This is a renewal application of an RO1 grant to study tolerance in peripheral B cells. Several lines of evidence, including prior work on this grant, have shown that peripheral B cell tolerance occurs, often by deletion. This tolerance is a barrier to the development of autoimmune disease. However, B cells in the periphery must also be capable of responding to foreign antigens. B lymphocytes are regulated by many signaling pathways that ensure appropriate development, activation and immune tolerance. In this proposal we focus on three pathways that regulate the development of B cell subsets in the peripheral immune system, peripheral B cell tolerance to tissue specific self-antigens, and the T-independent antibody response. Mutations affecting signaling pathways for toll-like receptors, cell surface inhibitory receptors and receptors for the TNF family cytokine BAFF will be used to probe their roles in B cell autonomous biological responses. The first Aim assesses B cell development, B cell tolerance and TI-2 responses in mice deficient in all Tlr signaling. In Aim 2, the effects on peripheral B cell tolerance and the TI-2 response of suppressing or eliminating SHP-1 in B cells will be assessed. Experiments in Aim 3 test the prediction that TACI-deficient B cells have a specific peripheral tolerance defect owing to dysregulated BAFF signaling and attempt to define the B cell autonomous role of TACI in the TI-2 response. The long term goals of these studies are to understand how the self/non-self discrimination is made, what goes wrong in the development of autoimmunity, and to identify ways that these mechanisms may be manipulated to ameliorate or prevent disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of PLD3 in nucleic acid recognition and brain function
-
批准号:10525053
-
项目类别:
-
资助金额:$133.13万
-
财政年份:2022
-
负责人:DAVID NEMAZEE
-
依托单位:
Role of PLD3 in nucleic acid recognition and brain function
-
批准号:10388543
-
项目类别:
-
资助金额:$44.38万
-
财政年份:2021
-
负责人:DAVID NEMAZEE
-
依托单位:
Immune Tolerance in Non-Clonal Immune Systems
-
批准号:9546043
-
项目类别:
-
资助金额:$53.47万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies
-
批准号:10190786
-
项目类别:
-
资助金额:$67.91万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies
-
批准号:10436822
-
项目类别:
-
资助金额:$67.91万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Functions of novel phospholipase D proteins in nucleic acid sensing
-
批准号:10405523
-
项目类别:
-
资助金额:$48.38万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Functional Analysis of MicroRNAs and Target Genes in Immune Tolerance
-
批准号:10159204
-
项目类别:
-
资助金额:$64.94万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies
-
批准号:9973126
-
项目类别:
-
资助金额:$67.91万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Functions of novel phospholipase D proteins in nucleic acid sensing
-
批准号:9810386
-
项目类别:
-
资助金额:$48.38万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Functions of novel phospholipase D proteins in nucleic acid sensing
-
批准号:10630110
-
项目类别:
-
资助金额:$48.38万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Functions of novel phospholipase D proteins in nucleic acid sensing
-
批准号:10159840
-
项目类别:
-
资助金额:$48.38万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Functional Analysis of MicroRNAs and Target Genes in Immune Tolerance
-
批准号:10405534
-
项目类别:
-
资助金额:$64.94万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies
-
批准号:10641828
-
项目类别:
-
资助金额:$63.53万
-
财政年份:2019
-
负责人:DAVID NEMAZEE
-
依托单位:
Germline targeting influenza immunogens
-
批准号:9363697
-
项目类别:
-
资助金额:$141.77万
-
财政年份:2017
-
负责人:DAVID NEMAZEE
-
依托单位:
Germline targeting influenza immunogens
-
批准号:10226016
-
项目类别:
-
资助金额:$139.41万
-
财政年份:2017
-
负责人:DAVID NEMAZEE
-
依托单位:
Designing and optimizing candidate HIV vaccines and boosting protocols
-
批准号:10053304
-
项目类别:
-
资助金额:$96.23万
-
财政年份:2016
-
负责人:DAVID NEMAZEE
-
依托单位:
Designing and optimizing candidate HIV vaccines and boosting protocols
-
批准号:9246148
-
项目类别:
-
资助金额:$96.23万
-
财政年份:2016
-
负责人:DAVID NEMAZEE
-
依托单位:
Analysis of the immunological role of Phospholipase D4
-
批准号:8495932
-
项目类别:
-
资助金额:$13.36万
-
财政年份:2012
-
负责人:DAVID NEMAZEE
-
依托单位:
Analysis of the immunological role of Phospholipase D4
-
批准号:8356431
-
项目类别:
-
资助金额:$37.9万
-
财政年份:2012
-
负责人:DAVID NEMAZEE
-
依托单位:
Functional analysis of Phospholipase D4
-
批准号:7871481
-
项目类别:
-
资助金额:$23.5万
-
财政年份:2009
-
负责人:DAVID NEMAZEE
-
依托单位:
海外基金